Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
JCSE01 - Joint IASLC-CSCO-CAALC Session
- 07:00 - 11:15
- 9/07/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Joint IASLC-CSCO-CAALC Session
- Track:
- Moderators:Chunxue Bai, Tony Mok, Yi-Long Wu, Qing Zhou, Nan Wu
-
+
JCSE01.09 - A Phase II Umbrella Study of Camrelizumab in Different PD-L1 Expression Cohorts in Pre-Treated Advanced/Metastatic Non-Small Cell Lung Cancer
09:45 - 09:55 | Presenter: Yi-Long Wu | Author(s): Cheng Huang, Yun Fan, Jifeng Feng, Hong-ming Pan, Liyan Jiang, Jin-Ji Yang, Xing-Ya Li, Xiao-Qing Liu, Jiang-Ping Xiong, Yan-Qiu Zhao, Ying Cheng, rui Ma, Jie Wang, Yi-Na Wang, Yan-Hui Liu, Dong-Mei Lin, Wei Shi, Xiang Lin
- Abstract
Loading... -
+
JCSE01.10 - Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Non-Small Cell Lung Cancer
09:55 - 10:05 | Presenter: Shuhang Wang | Author(s): Ning Li, Jianming Ying, Xiuli Tao, Fan Zhang, Ziran Zhao, Yun Ling, Yushun Gao, Jun Zhao, Qi Xue, Yousheng Mao, Wendong Lei, Ning Wu, Jianchun Duan, Yibo Gao, Zhijie Wang, Nan Sun, Jie Wang, Shugeng Gao, Jie He, Hui Zhou, Shuyan Wang
- Abstract
Loading...
-
+
OA03 - Systemic Therapies for SCLC: Novel Targets and Patients' Selection
- 13:30 - 15:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Christine Lee Hann, Makoto Nishio
-
+
OA03.02 - Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial
13:40 - 13:50 | Presenter: Qiming Wang | Author(s): Ying Cheng, Kai Li, Jianhua Shi, Baohui Han, Lin Wu, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiao-Ling Li
- Abstract
Loading...
-
+
EP1.14 - Targeted Therapy
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
EP1.14-49 - A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Exploratory Biomarker Analysis
08:00 - 08:00 | Presenter: Jie Wang | Author(s): Jun Zhao, Hua Bai, Xin Wang, Yuyan Wang, Jianchun Duan, Hanxiao Chen, Zhiyi Xue, Susan Meng, Yahui Tian, Agnieszka Cseh, Dennis Chin-Lun Huang, Yi-Long Wu
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-106 - Clinical Features and Tumor Immune Microenvironment Related to Acquired Resistance to EGFR-TKI in NSCLC Patients with EGFR Mutation
09:45 - 09:45 | Presenter: Pei Zhang | Author(s): Lingfang Tu, Rong Liu, Xuanli Xu, Zhang Bao, Panfeng Xu, Jie Wang, Hequan Li, Jianying Zhou, Yuehong Wang
- Abstract
Loading... -
+
P1.01-61 - A Phase II Umbrella Study of Camrelizumab in Different PD-L1 Expression Cohorts in Pre-Treated Advanced/Metastatic Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yi-Long Wu | Author(s): Cheng Huang, Yun Fan, Jifeng Feng, Hong-ming Pan, Liyan Jiang, Jin-Ji Yang, Xing-Ya Li, Xiao-Qing Liu, Jiang-Ping Xiong, Yan-Qiu Zhao, Ying Cheng, rui Ma, Jie Wang, Yi-Na Wang, Yan-Hui Liu, Dong-Mei Lin, Wei Shi, Xiang Lin
- Abstract
Loading...
-
+
P1.18 - Treatment of Locoregional Disease - NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Locoregional Disease - NSCLC
-
+
P1.18-06 - Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Shuhang Wang | Author(s): Ning Li, Jianming Ying, Xiuli Tao, Fan Zhang, Ziran Zhao, Yun Ling, Yushun Gao, Jun Zhao, Qi Xue, Yousheng Mao, Wendong Lei, Ning Wu, Jianchun Duan, Yibo Gao, Zhijie Wang, Nan Sun, Jie Wang, Shugeng Gao, Jie He, Hui Zhou, Shuyan Wang
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-45 - Clinico-Molecular Characteristics and Prognostic Outcomes of TP53 Mutated Patients with Advanced Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Zizheng Song | Author(s): Huanqing Cheng, Ling Hu, Qiang Han, Xiaolei Wang, Yue Huo, Ting Jiao, Guanying Ren, Kunjie Wang, Baoyu Yin, Youchao Jia, Jin Song, Huina Wang, Feng Lou, Shanbo Cao, Aimin Zang
- Abstract
Loading...
-
+
P2.12 - Small Cell Lung Cancer/NET
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P2.12-11 - Quality of Life in ALTER1202 Trial of Anlotinib as Third-or Further Line Therapy for Advanced Small Cell Lung Cancer (SCLC): A Post-Hoc Analysis
10:15 - 10:15 | Presenter: Kai Li | Author(s): Ying Cheng, Qiming Wang, Jianhua Shi, Baohui Han, Lin Wu, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiaolin Li
- Abstract
Loading... -
+
P2.12-26 - The Impact of Anlotinib for Relapsed SCLC Patients with Brain Metastases: A Subgroup Analysis of ALTER 1202
10:15 - 10:15 | Presenter: Ying Cheng | Author(s): Qiming Wang, Kai Li, Jianhua Shi, Baohui Han, Lin Wu, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiao-Ling Li
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.02 - Genomic Origin and EGFR-TKI Efficacy of Pulmonary Adenosquamous Carcinoma
14:35 - 14:40 | Presenter: Gen Lin | Author(s): Chao Li, Pansong Li, Wenzhang Fang, Haipeng Xu, Yuhua Gong, Zhengfei Zhu, Yi Hu, Wenhua Liang, Qian Chu, Wen-Zhao Zhong, Lin Wu, Huijuan Wang, Zhijie Wang, Ziming Li, Jie Lin, Yan-Fang Guan, Xuefeng Xia, Xin Yi, Qian Miao, Biao Wu, Kang Jiang, Xiaobin Zheng, Weifeng Zhu, Xinlong Zheng, Huang Peisha, Xiao Wenjin, Dan Hu, Longfeng Zhang, Xirong Fan, Tony Mok, Cheng Huang
- Abstract
Loading...
